KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Total Liabilities (2016 - 2025)

Johnson & Johnson (JNJ) has disclosed Total Liabilities for 17 consecutive years, with $117.7 billion as the latest value for Q4 2025.

  • Quarterly Total Liabilities rose 8.33% to $117.7 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $117.7 billion through Dec 2025, up 8.33% year-over-year, with the annual reading at $117.7 billion for FY2025, 8.33% up from the prior year.
  • Total Liabilities hit $117.7 billion in Q4 2025 for Johnson & Johnson, up from $113.5 billion in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $125.1 billion in Q2 2023 to a low of $94.8 billion in Q4 2023.
  • Historically, Total Liabilities has averaged $108.7 billion across 5 years, with a median of $108.6 billion in 2024.
  • Biggest five-year swings in Total Liabilities: grew 20.7% in 2023 and later dropped 18.51% in 2024.
  • Year by year, Total Liabilities stood at $109.0 billion in 2021, then fell by 7.74% to $100.5 billion in 2022, then fell by 1.73% to $98.8 billion in 2023, then rose by 9.95% to $108.6 billion in 2024, then rose by 8.33% to $117.7 billion in 2025.
  • Business Quant data shows Total Liabilities for JNJ at $117.7 billion in Q4 2025, $113.5 billion in Q3 2025, and $114.9 billion in Q2 2025.